Finished
Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors
NCT04400357 · Ruijin Hospital · Updated 18 Dec 2025
- What is being tested
- Robotic pancreaticoduodenectomy; Open pancreaticoduodenectomy
- For
- Pancreatic Adenocarcinoma; Pancreatic Cysts; Pancreatic Endocrine Tumors; Chronic Pancreatitis; Cholangiocarcinoma, Extrahepatic; Ampullary Adenocarcinoma; Duodenal Adenocarcinoma
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 268 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 28 Sept 2020, ends 28 Feb 2025. Registered 22 May 2020.
- Results
- None posted yet.
In the researchers' words
This multicenter randomized trial aims to primarily assess and compare the functional recovery of patients who undergo open versus robotic pancreaticoduodenectomy for benign and malignant lesions of the head of the pancreas.
Sites
- Ruijin Hospital Shanghai Jiaotong University School of MedicineShanghai, Shanghai Municipality, China